Canada's Health Minister sets out plan to help reduce impact of drug shortages

16 September 2013

A national protocol for the public notification of drug shortages and a toolkit that identifies steps that can be taken to prevent and reduce the impact of drug shortages was announced in Canada last Friday (September 13). The protocol and toolkit are designed to put the health and safety of Canadian patients first when communicating about drug shortages.

"Our government understands the potential impact of drug shortages," said Health Minister Rona Ambrose, adding: "We are taking action and working together with all stakeholders across the healthcare system. This announcement reinforces that all levels of government and all parts of the supply chain have a role to play in communicating, addressing and preventing shortages."

The announcement will give doctors, pharmacists, health care practitioners and all stakeholders clear and concise information on drug shortages, so they can make the best decisions for their patients.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Generics